NCT03516110

Health Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist Therapy

Health Related Quality of Life and Multidimensional Evaluations of a Cohort of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist Therapy

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 831 (actual)
• Sponsor: Ipsen · Industry
• Sex: Male
• Age: 60 Years
• Healthy volunteers: Not accepted

Summary

The objective of the study is to compare the evolution over 6 months of Health-Related Quality of Life (HRQOL) among different age groups in subjects with prostate cancer treated with GnRH agonist therapy.

Detailed description

Relevant data collected as part of routine medical care will be captured on an electronic Case Report Form (eCRF). Investigator-subject questionnaires and subject self-questionnaires answers will be collected in a paper booklet. This study is non-interventional, thus if some assessments, are not routinely performed by the investigator, he/she will not complete the corresponding sections in the eCRF.

Conditions

• Prostate Cancer

Interventions

Type	Name	Description
OTHER	Data collection	Subjects will be treated in accordance with usual medical practice during their participation in this study. No additional assessments or tests will be required.

Timeline

• Start date: 2018-03-09
• Primary completion: 2020-02-28
• Completion: 2020-02-28
• First posted: 2018-05-04
• Last updated: 2026-01-23

Locations

1 site across 1 country: France